Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021.
Pomat W, Lopez Cavestany R, Jeyaseelan V, Ford R, Gare J, Avagyan T, Grabovac V, Bettels D, Mekonnen D, Jones KAV, Mainou BA, Mach O. Pomat W, et al. Among authors: jeyaseelan v. Lancet Reg Health West Pac. 2023 Dec 20;44:100986. doi: 10.1016/j.lanwpc.2023.100986. eCollection 2024 Mar. Lancet Reg Health West Pac. 2023. PMID: 38204497 Free PMC article.
Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial.
Sharma AK, Verma H, Estivariz CF, Bajracharaya L, Rai G, Shah G, Sherchand J, Jones KAV, Mainou BA, Chavan S, Jeyaseelan V, Sutter RW, Shrestha LP. Sharma AK, et al. Among authors: jeyaseelan v. Lancet Microbe. 2023 Nov;4(11):e923-e930. doi: 10.1016/S2666-5247(23)00215-X. Epub 2023 Sep 26. Lancet Microbe. 2023. PMID: 37774729 Free PMC article. Clinical Trial.
Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.
Trueba G, Jeyaseelan V, Lopez L, Mainou BA, Zhang Y, Whittembury A, Valarezo AJO, Baquero G, de Aguinaga RR, Salinas LJZ, Mancheno MGS, Chacho DEM, Quentin E, Chevez AE, Rey-Benito G, Mach O. Trueba G, et al. Among authors: jeyaseelan v. Lancet Reg Health Am. 2022 Jul;11:None. doi: 10.1016/j.lana.2022.100235. Lancet Reg Health Am. 2022. PMID: 35865654 Free PMC article.
Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam.
Huyen DTT, Anh DD, Trung NT, Hong DT, Thanh TT, Truong LN, Jeyaseelan V, Lopez Cavestany R, Hendley WS, Mainou BA, Mach O. Huyen DTT, et al. Among authors: jeyaseelan v. J Pediatric Infect Dis Soc. 2022 Sep 29;11(9):413-416. doi: 10.1093/jpids/piac046. J Pediatric Infect Dis Soc. 2022. PMID: 35801634 Free PMC article.
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
Bashorun AO, Badjie Hydara M, Adigweme I, Umesi A, Danso B, Johnson N, Sambou NA, Fofana S, Kanu FJ, Jeyaseelan V, Verma H, Weldon WC, Oberste MS, Sutter RW, Jeffries D, Wathuo M, Mach O, Clarke E. Bashorun AO, et al. Among authors: jeyaseelan v. Lancet Glob Health. 2022 Feb;10(2):e257-e268. doi: 10.1016/S2214-109X(21)00497-6. Epub 2021 Dec 21. Lancet Glob Health. 2022. PMID: 34951974 Free PMC article. Clinical Trial.
81 results